BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4666121)

  • 1. Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia.
    Miettinen TA
    Atherosclerosis; 1972; 15(2):163-76. PubMed ID: 4666121
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nicotinic acid on catabolism and synthesis of cholesterol in man.
    Miettinen TA
    Clin Chim Acta; 1968 Apr; 20(1):43-51. PubMed ID: 5652004
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man.
    Sodhi HS; Kudchodkar BJ; Horlick L; Weder CH
    Metabolism; 1971 Apr; 20(4):348-59. PubMed ID: 5550302
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased cholesterol-biosynthesis in familial hypercholesterolemia.
    Chida N; Okamura T
    Tohoku J Exp Med; 1971 Oct; 105(2):147-55. PubMed ID: 5140375
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of glycyrrhizin and cortisone on cholesterol metabolism in the rat.
    Yamamoto M; Takeuchi N; Kotani S; Kumagai A
    Endocrinol Jpn; 1970 Oct; 17(5):339-48. PubMed ID: 5537368
    [No Abstract]   [Full Text] [Related]  

  • 6. Leucine and mevalonate as precursors of serum cholesterol in man.
    Miettinen TA; Penttilä IM
    Acta Med Scand; 1968 Sep; 184(3):159-64. PubMed ID: 5703971
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR; Kelly LA; Ho RS; Trapold JH
    Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract]   [Full Text] [Related]  

  • 8. Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism.
    Grundy SM; Ahrens EH; Salen G
    J Lab Clin Med; 1971 Jul; 78(1):94-121. PubMed ID: 5569253
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of desoxymevalonic acid derivatives on development of triton hyperlipemia in rats].
    Klimov AN; Klimova TA; Poliakova ED; Dizhe EB; Petrova LA
    Vopr Med Khim; 1974; 20(1):65-9. PubMed ID: 4454273
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of cholesterol in hypercholesterolemia and its relationship to plasma trigylcerides.
    Sodhi HS; Kudchodkar BJ
    Metabolism; 1973 Jul; 22(7):895-912. PubMed ID: 4351067
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of a hypolipidaemic drug (CH 13,437) on plasma and tissue lipids, and on the intravenous fat tolerance in man.
    Boberg J; Carlson LA; Fröberg SO; Orö L
    Atherosclerosis; 1970; 11(2):353-60. PubMed ID: 4353910
    [No Abstract]   [Full Text] [Related]  

  • 12. The hypolipemic properties of 5 beta-cholanic acid in the mouse and rat.
    Howe EE; Bosshardt DK; Gilfillan J; Hunt VM; Huff JW
    Arch Biochem Biophys; 1969 Jan; 129(1):264-76. PubMed ID: 5773747
    [No Abstract]   [Full Text] [Related]  

  • 13. Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man.
    Horlick L; Kudchodkar BJ; Sodhi HS
    Circulation; 1971 Feb; 43(2):299-309. PubMed ID: 5540713
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypocholesterolemic agents and mobilization of tissue cholesterol in man.
    Sodhi HS; Kudchodkar BJ; Horlick L
    Atherosclerosis; 1973; 17(1):1-19. PubMed ID: 4696743
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of action of cholestyramine in the treatment of hypercholesterolemia.
    Nazir DJ; Horlick L; Kudchodkar BJ; Sodhi HS
    Circulation; 1972 Jul; 46(1):95-102. PubMed ID: 5039828
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of halofenate on serum lipids.
    Aronow WS; Harding PR; Khursheed M; Vangrow JS; Papageorge's NP; Mays J
    Clin Pharmacol Ther; 1973; 14(3):358-65. PubMed ID: 4572798
    [No Abstract]   [Full Text] [Related]  

  • 17. Faecal fat, bile acid excretion, and body height in familial hypercholesterolaemia and hyperglyceridaemia.
    Miettinen TA; Aro A
    Scand J Clin Lab Invest; 1972 Sep; 30(1):85-8. PubMed ID: 5073094
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

  • 19. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
    Roe DA
    Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of cholesterol biosynthesis by mevalonic acid derivatives].
    Klimov AN; Klimova TA; Petrova LA; Poliakova ED
    Biokhimiia; 1971; 36(4):851-6. PubMed ID: 5095969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.